Font Size

Non-Small-Cell Lung Cancer (cont.)


Surgical removal of the tumor provides the best chance of long-term, disease-free survival and the possibility of a cure. In stages I and II NSCLC, removal of the tumor by surgery is almost always possible unless the person is ineligible for surgery because of other medical conditions or complications of the tumor. (These patients usually receive radiation therapy.) Generally, only some stage IIIA cancers are operable. Persons with stage IIIB or IV tumors are generally not candidates for surgery.
Only 30-35% of people with NSCLC have operable tumors. Approximately 50% of people who undergo surgery have a relapse after surgery.
Before a patient can undergo surgery for lung cancer, he undergoes pulmonary function tests to make sure his lungs are strong enough.
The standard operations for lung cancer include lobectomy (removal of one lobe of the lung) or pneumonectomy (removal of the whole lung). Attempts to remove a smaller part of the lung (wedge resections) carry a higher risk of recurrence and poor outcome.
Like all operations, these procedures have benefits and risks. All operations carry a risk of complications, both from the operation itself and from the anesthesia. The surgeon discusses these benefits and risks with the patient. Together, they decide whether the patient is a candidate for surgery.

Medical Author:
Medical Editor:
Medical Editor:
Medical Editor:

Must Read Articles Related to Non-Small-Cell Lung Cancer

Small-Cell Lung Cancer
Small-Cell Lung Cancer When cells of the lung start growing rapidly in an uncontrolled manner, the condition is called lung cancer. Lung cancer can affect any part of the lung. Lung c...learn more >>
Lung Cancer Medications
Understanding Lung Cancer Medications Medical therapy options for lung cancer include surgery, radiation, and/or chemotherapy. These treatments help decrease tumor growth and size. When tumor growth...learn more >>

Read What Your Physician is Reading on Medscape

Lung Cancer, Non-Small Cell »

Worldwide, bronchogenic carcinoma is the most common cause of cancer death in both men and in women.

Read More on Medscape Reference »

Medical Dictionary